RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+21.69%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.03B
AUM Growth
+$2.03B
(+25%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
7.95%
Top 10 Holdings %
Top 10 Hldgs %
49.69%
Holding
77
New
15
Increased
27
Reduced
15
Closed
12
Top Buys
| 1 |
AstraZeneca
AZN
|
$76.1M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$64.1M |
| 3 |
Insmed
INSM
|
$61.8M |
| 4 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$52.1M |
| 5 |
AET
Aetna Inc
AET
|
$37.2M |
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$66.3M |
| 2 |
Elevance Health
ELV
|
$43.6M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$35M |
| 4 |
Penumbra
PEN
|
$33M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$30M |
Sector Composition
| 1 | Healthcare | 89.36% |
| 2 | Financials | 3.41% |
| 3 | Communication Services | 0.62% |
| 4 | Energy | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$102B
| $28.7M | 1.42% |
189,008
+44,600
| +31% | +$6.78M |
|
27
iRhythm Technologies
IRTC
$5.67B
| $28.6M | 1.41% |
552,041
+75,700
| +16% | +$3.93M |
|
28
Xencor
XNCR
$594M
| $27.5M | 1.36% |
1,200,294
+12,800
| +1% | +$293K |
|
|
LJPC
29
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $25.2M | 1.24% |
723,330
+10,050
| +1% | +$350K |
|
|
EPZM
30
DELISTED
Epizyme, Inc
EPZM
| $23.1M | 1.14% |
+1,210,000
| New | +$23.1M |
|
|
CMRX
31
DELISTED
Chimerix, Inc.
CMRX
| $22.2M | 1.09% |
4,225,575
+18,000
| +0.4% | +$94.5K |
|
|
DPLO
32
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $19.8M | 0.98% |
+957,155
| New | +$19.8M |
|
|
NVTA
33
DELISTED
Invitae Corporation
NVTA
| $19.8M | 0.98% |
2,112,240
+1,300,000
| +160% | +$12.2M |
|
34
Boston Scientific
BSX
$159B
| $17.6M | 0.87% |
603,493
-491,490
| -45% | -$14.3M |
|
|
CBIO
35
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $17M | 0.84% |
1,214,088
+614,468
| +102% | +$8.6M |
|
36
Medpace
MEDP
$13.5B
| $15.9M | 0.79% |
499,640
+274,600
| +122% | +$8.76M |
|
|
AMED
37
DELISTED
Amedisys
AMED
| $15.9M | 0.78% |
283,648
+280,292
| +8,352% | +$15.7M |
|
|
JNCE
38
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $14.9M | 0.73% |
955,598
-182,772
| -16% | -$2.85M |
|
|
SYNH
39
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $14M | 0.69% |
267,918
-573,500
| -68% | -$30M |
|
|
CBAY
40
DELISTED
Cymabay Therapeutics
CBAY
| $13.3M | 0.65% |
+1,647,100
| New | +$13.3M |
|
|
LUMO
41
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $12.7M | 0.63% |
+1,248,700
| New | +$12.7M |
|
|
MODN
42
DELISTED
MODEL N, INC.
MODN
| $12.5M | 0.62% |
838,914
-19,400
| -2% | -$290K |
|
|
DCPH
43
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $12M | 0.59% |
+722,880
| New | +$12M |
|
|
ATYR
44
aTyr Pharma
ATYR
$560M
| $9.53M | 0.47% |
+1,886,792
| New | +$9.53M |
|
|
SYRS
45
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $9.44M | 0.47% |
641,419
-331,841
| -34% | -$4.88M |
|
|
CASC
46
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $8.06M | 0.4% |
1,969,969
-1,766,025
| -47% | -$7.22M |
|
47
ProQR Therapeutics
PRQR
$256M
| $7.77M | 0.38% |
1,602,975
+6,700
| +0.4% | +$32.5K |
|
48
Teleflex
TFX
$5.57B
| $7.59M | 0.37% |
+31,365
| New | +$7.59M |
|
49
CytomX Therapeutics
CTMX
$350M
| $6.95M | 0.34% |
382,271
-316,121
| -45% | -$5.74M |
|
|
PETQ
50
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $6.68M | 0.33% |
+246,743
| New | +$6.68M |
|